Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 May 7;19(9):5682.
doi: 10.3390/ijerph19095682.

Treatment of Peri-Implant Mucositis with Standard of Care and Bioptron Hyperlight Therapy: A Randomized Clinical Trial

Gianna Maria Nardi  1 , Marta Mazur  1 , Giulio Papa  1 , Massimo Petruzzi  2 , Felice Roberto Grassi  3 , Roberta Grassi  4
Affiliations
Randomized Controlled Trial

Treatment of Peri-Implant Mucositis with Standard of Care and Bioptron Hyperlight Therapy: A Randomized Clinical Trial

Gianna Maria Nardi et al. Int J Environ Res Public Health. .

Abstract

The aim of this study was to evaluate in a cohort of patients with peri-implant mucositis: (a) the efficacy of professional mechanical debridement therapy assisted using Bioptron Hyperlight Therapy on the reduction in periodontal indexes and (b) the reduction in total oxidative salivary stress. Forty subjects with a diagnosis of peri-implant mucositis were enrolled and randomly assigned to the Study Group (mechanical debridement therapy assisted using Bioptron Hyperlight Therapy) or Control Group (mechanical debridement therapy alone). The study duration was 6 months. Data on plaque index (PI), bleeding on probing (BoP), probing pocket depth (PPD), and pain relief on Visual Analogue Scale (VAS) were recorded at T0, T1 (14 days), T2 (1 month), and T3 (6 months). Group differences were assessed using Student's t-test and Pearson's Chi-squared test of homogeneity. PI and PPD decreased in the Study Group at the [T0; T1] time interval and during the overall time of observation significantly more than in the Control Group; BoP and pain on VAS decreased significantly faster in the Study Group than in the Control Group. Differences in Salivary Antioxidant Test (SAT) changes were not significant at any time interval. Patients' gender and smoking habit were not correlated with the clinical outcomes. Clinical parameters related to peri-implant mucositis significantly improved in the Study Group, which demonstrated the clinical efficacy of the Bioptron Hyperlight Therapy as an adjunct to standard of care for the treatment of peri-implant mucositis. The RCT was registered at the US National Institutes of Health #NCT05307445.

Keywords: Bioptron; SAT; clinical trial; dental hygiene; dental implants; non-surgical periodontal therapy; oxidative stress; peri-implant mucositis; photobiomodulation; salivary test.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
Distribution of changes in plaque index (percentage points).
Figure 3
Figure 3
Distribution of changes in PPD.
Figure 4
Figure 4
Distribution of changes in SAT.
See this image and copyright information in PMC

References

    1. Renvert S., Persson G.R., Pirih F.Q., Camargo P.M. Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. J. Periodontol. 2018;89:S304–S312. doi: 10.1002/JPER.17-0588. - DOI - PubMed
    1. Rosen P., Clem D., Cochran D., Froum S., McAllister B., Renvert S., Wang H.L. Peri-implant mucositis and peri-implantitis: A current understanding of their diagnoses and clinical implications. J. Periodontol. 2013;84:436–443. - PubMed
    1. Heitz-Mayfield L.J.A., Salvi G.E. Peri-implant mucositis. J. Clin. Periodontol. 2018;45:S237–S245. doi: 10.1111/jcpe.12953. - DOI - PubMed
    1. Berglundh T., Armitage G., Araujo M.G., Avila-Ortiz G., Blanco J., Camargo P.M., Chen S., Cochran D., Derks J., Figuero E., et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018;45:S286–S291. doi: 10.1111/jcpe.12957. - DOI - PubMed
    1. Figuero E., Graziani F., Sanz I., Herrera D., Sanz M. Management of peri-implant mucositis and peri-implantitis. Periodontol 2000. 2014;66:255–273. doi: 10.1111/prd.12049. - DOI - PubMed

Publication types

Associated data